Indian Institute of Technology (IIT Madras) and NASA’s Jet Propulsion Laboratory (JPL) researchers are studying multi-drug resistant pathogens on the International Space Station (ISS), which could have key applications for astronauts health as well on Earth.
The researchers conducted a comprehensive study to understand the genomic, functional, and metabolic enhancements observed in multidrug-resistant pathogens with a particular focus on Enterobacter bugandensis, a prevalent nosocomial pathogen found on surfaces within the ISS, stated a press release from the institute.
Astronauts operating in altered immune conditions with limited access to traditional medical facilities face unique health challenges during space missions. Understanding the microbial landscape aboard the ISS is paramount for assessing the impact of these microorganisms on astronaut well-being.
The current study emphasises the critical need to investigate the pathogenic potential of microorganisms in space environments to safeguard astronaut health and mitigate the risks associated with opportunistic pathogens.
The collaborative efforts between IIT Madras and NASA’s JPL underscore the importance of international partnerships in advancing scientific knowledge and addressing the challenges of space exploration. Published in the esteemed journal Microbiome.
This research represents a significant advancement in understanding microbial dynamics in confined environments.
